Market Scale with Huge Potential from $28 Million to $257 Million

In 1975, Bartlett, from the University of Michigan School of Medicine, cured an infant successfully with persistent fetal circulation in ECMO. Until the 1980s, ECMO was considered into the construction of ICU. Under this epidemic. ECMO has saved the life of the patients suffering from serious NCP, counted officially as the treatment plan for the NCP diagnosis, which has increased the demand of ECMO among a large number of hospitals. And the society from all walks centralized over 100 ECMO equipment to support Wuhan, the epidemic center, but not enough.

ECMO is a simulated model of our heart and lung to help the patients with the cardiopulmonary disease breath and keep living, whose principle is that the blood is drawn out from the vein, flows through the membrane oxygenator to oxygenate hemoglobin and remove carbon dioxide, then, the blood that has passed through the gas exchange is transmitted back to the patient body.

High Cost of ECMO Treatment with $7,100 Starting

The average price of the ECMO device is about $235,700 and other costs such as keeping-detection and medicine are also pretty high, which results that the fee to start ECMO reaches over $7,100 that is lower than the expense abroad with more than $14,200.



With Low Holding Rate in China and Difficult to Localize

It is widely utilized by many developed countries such as Germany with an average of one ECMO per 40,000 people. But in China, a total of 500 ECMO is distributed to 260 hospitals with an average of one ECMO per 2,800,000 people.

Key Material and Technology Are the Two Most Significant Factories to Hinder the Localization

There is an essential material, a solid fiber of PMP in the core steps, which makes oxygen enter the blood efficiently and requires to take regular replacement. There is only one supplier to offer the solid fiber of PMP, leading to the great limitation of its capacity. At present, there are only 5 companies in the world that can produce artificial lung with two in the US, two in Germany and one in Japan.  Without exception, they have monopolized the pulmonary membrane technology as the absolute secret technology.

 ECMO Market with Huge Potential in China

The development of ECMO is attributable to the improving awareness of ICU that is forced to build among the hospitals above grade two. ECMO is a very important equipment in ICU and the treatment of severe disease patients cannot be separated from ECMO. In 2018, the number of beds in the critical care department in China reached 52,560, with a CAGR of 19.62% from 2007 to 2018. There were 2,548 tertiary hospitals in China, of which 1,442 were class-A, of which only 260 were able to carry out ECMO treatment. The development of ECMO in China has a long way to go. It is predicted that the market scale of ECMO will be $257 million according to the current price with $235,700 per device and $7,100 per piece under the assumption that each class-A hospital possesses one ECMO and 5 percent patients need ECMO treatment.

In view of the importance of ECMO in the critical area and the promotion of the epidemic, we believe that relevant companies will benefit from it and introduce two companies, BOLATE and Jafron.





As the most advanced technology in the field of emergency treatment, ECMO represents the rescue level of critical areas in a hospital, even in a region and a country. The popularity of ECMO is a long process related to the device supply, the concept of the public and the country finance, which will not be the obstacle but the driver motor.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.